Neureka® for Epilepsy

Epilepsy care reimagined: AI-powered wearables for on-demand care, 24/7

Print
Claim My Business
Form C
View on Republic
Security Type
Crowd SAFE
Min Investment
$150
Location
ALAMEDA, CA
Offering Date
July 18, 2022
Expected Close Date
April 15, 2023
Target Raise
$25.00K-$1.24M
No. Investors
76
Security Price
$1
Website
neureka.ai
Number of Employees
2
Cash
$281,299
Revenue
$0
Short Term Debt
$50,065
Cost of Goods
$0
Long Term Debt
$20,171
Net Income
$-1,393,497

Company Description

For many people with epilepsy, getting on the right treatment is a painfully slow process. It can be overwhelming to track seizures, medications, side effects, and sleep, and share accurate information with doctors. This all adds up to poor treatment decisions and long patient journeys toward seizure freedom.

Perks

Reserve
$500
Receive
Neureka® coffee & tea mug

Reserve
$1,000
Receive
Neureka® coffee & tea mug
Neureka® Sleep 10% discount for 1 year

Reserve
$2,500
Receive
All of the above PLUS
Early access to Neureka® seizure-detection wearables

Reserve
$5,000
Receive
All of the above PLUS
Feature on our website’s hall of fame

Reserve
$10,000
Receive
All of the above PLUS
Your own personalized investor page on our website, with 10% discounts for your friends & family

Reserve
$25,000
Receive
All of the above PLUS
Healthy lunch or dinner with our founder & CEO and an opportunity to meet the team

Reserve
$50,000
Receive
All of the above PLUS
A vote in our roadmap and product development features

Reserve
$100,000
Receive
All of the above PLUS
Lifetime 25% discount on all Neureka® products and services, shareable with friends & family

Reserve
$250,000
Receive
All of the above PLUS
Invitation to attend & vote at our annual investor meeting

Key Deal Facts

Neureka® provides AI-powered wearables for on-demand, 24/7 epilepsy care
Instant alerts to improve medication adherence & deliver preventative care
Neureka® Sleep offers peace of mind during sleep, when SUDEP can strike
Incredibly accurate FDA-cleared seizure-detection & alerting wearables
10+ years of R&D coming to market, with $4.5M raised
Accelerating B2C market traction & US epilepsy center partnerships
Market frontier includes sleep disorders, migraine, and more

Management Team / Advisory Board Bios

Ray Iskander
Founder

Parisa Sabetian, PhD
Chief Scientific Officer & Co-Founder

Kramay Patel, PhD
Chief Platform Officer

John Stern, MD
Chair, Scientific Advisory Board

Vikram Rao, MD, PhD
Member, Scientific Advisory Board
Amount Raised : $74,921
Reveal the Score by Voting
＿
Additional ratings from other users are needed to determine a viable CrowdScore for this deal.
The "CrowdScore" for this deal is determined by user ratings and other factors using our proprietary algorithm.
ⓘ
The overall viability and scalability of the business concept as well as the ability to drive the concept to profitability over time.
Business Idea
ⓘ
The progress made thus far in demonstrating that the business has viability, a customer base or other business traction.
Business Traction
ⓘ
The experience of the management team in running, scaling and/or exiting a business that required similar skills to execute the business plan.
Management Team
ⓘ
The value of the company compared to similar companies raising money from investors.
Valuation

Security Description

An equity crowdfunding specific version of a SAFE used by crowdfunding portal Republic. Upon conversion (if and when that happens), investors may receive special shares with limited rights that do not show up on a company’s cap table. The issuer may roll over and not convert shares at the next financing round causing investors to lose out on some upside.

Research Reports

No reports have been submitted

Become a Reporter
Read Our Research Disclaimer

0 Comments

Post Comment